Cardiovascular Systems (FRA:R7Y1) Current Deferred Taxes Liabilities : €0.0 Mil (As of Dec. 2022)

View and export this data going back to 2012. Start your Free Trial

What is Cardiovascular Systems Current Deferred Taxes Liabilities?

Current Deferred Taxes Liabilities represent future tax liabilities, resulting from temporary differences between book (accounting) value of assets and liabilities and their tax value, or timing differences between the recognition of gains and losses in financial statements and their recognition in a tax computation. Deferred tax liabilities generally arise where tax relief is provided in advance of an accounting expense, or income is accrued but not taxed until received.

Cardiovascular Systems's current deferred tax liabilities for the quarter that ended in Dec. 2022 was €0.0 Mil.

Cardiovascular Systems Current Deferred Taxes Liabilities Historical Data

The historical data trend for Cardiovascular Systems's Current Deferred Taxes Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cardiovascular Systems Current Deferred Taxes Liabilities Chart

Cardiovascular Systems Annual Data

Trend

Jun13

Jun14

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Current Deferred Taxes Liabilities

Get a 7-Day Free Trial

Cardiovascular Systems Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22
Current Deferred Taxes Liabilities	Get a 7-Day Free Trial															-	-	-	-	-

Cardiovascular Systems Current Deferred Taxes Liabilities Related Terms

Thank you for viewing the detailed overview of Cardiovascular Systems's Current Deferred Taxes Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Cardiovascular Systems (FRA:R7Y1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cardiovascular Systems Inc (FRA:R7Y1) » Definitions » Current Deferred Taxes Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

1225 Old Highway 8 Northwest, Saint Paul, MN, USA, 55112-6416

Website

https://www.csi360.com

Cardiovascular Systems Inc is a medical technology company focused on patients with peripheral and coronary artery diseases. Its peripheral artery disease systems are catheter-based platforms used to treat plaque in leg arteries above and below the knee. The firm's orbital atherectomy systems are used in peripheral and coronary commercial applications. Its OAS products include the Diamondback 360 Peripheral and Stealth 360 systems. Sales of Peripheral OAS contribute the majority of revenue. Cardiovascular systems generate the vast majority of its revenue in the United States.

Cardiovascular Systems (FRA:R7Y1) Headlines

No Headlines